Labels Offer FDA Clues To Spiked Supplements, Health Fraud
This article was originally published in The Tan Sheet
Executive Summary
Claims that promise too much point FDA to products marketed as supplements that warrant investigation for health fraud, CFSAN’s Corey Hilmas tells USP workshop on economically motivated adulteration.
You may also be interested in...
Gaps In Spiked Supplement Net Could Shrink With Non-Targeted Screening
FDA plans to deploy testing technology that casts a wider net than its existing targeted adulterant tests, intending to catch product that may be tainted with as-yet-unknown adulterants.
DMAA Is Synthetic And Needs NDI Notification – Study
Botanical experts refute that DMAA is a geranium plant derivative and that the ingredient has been common in the food supply, as some supplement manufacturers have argued. “Elementary mathematics establishes that [DMAA] in dietary supplements must be synthetic,” study authors say.
FTC Intensifies Health Claims Scrutiny, Enforcement Strategies
A joint Federal Trade Commission/FDA working group will evaluate claims made for dietary supplements, conventional foods and OTC drugs, said the commission's Consumer Protection Director David Vladeck